Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Azoy Alexander | Chief Financial Officer | 15 | $0 | $0 | 2019-10-02 |
| Andrews Timothy K. | General Counsel & Secretary | 19 | $225.0K | $0 | 2019-08-06 |
| Lizzul Paul F. | Chief Medical Officer | 21 | $150.0K | $0 | 2019-08-06 |
| Beddingfield III Frederick | President & CEO | 26 | $100.0K | $0 | 2019-08-06 |
| Stroehmann Diane | See Remarks | 10 | $105.0K | $0 | 2019-07-02 |
| Harris Todd | Head of Corporate Development | 16 | $0 | $1.22M | 2019-05-30 |
| Hindman James M. | Director | 2 | $0 | $0 | 2019-05-30 |
| Burow Kristina | Director, 10% Owner | 14 | $5.41M | $0 | 2019-05-30 |
| Leonard Keith R | Director | 7 | $500.5K | $0 | 2019-05-30 |
| MORE ROBERT J | Director | 9 | $250.0K | $459.4K | 2019-05-30 |
| FENTON DENNIS M | Director | 3 | $28.7K | $0 | 2019-05-30 |
| ARCH Venture Partners VIII, L.P. | 10% Owner | 3 | $5.41M | $0 | 2019-02-22 |
| GILLIS STEVEN | 10% Owner | 3 | $5.41M | $0 | 2019-02-22 |
| Smither John W | Chief Financial Officer | 6 | $0 | $0 | 2019-01-01 |
| NELSEN ROBERT | Director, 10% Owner | 10 | $0 | $0 | 2018-06-01 |
| MAST ERLE T | Director | 2 | $100.5K | $0 | 2018-06-01 |
| ARCH Venture Fund VIII, L.P. | 10% Owner | 8 | $0 | $0 | 2017-08-01 |
| PETERSON RICHARD D | Chief Financial Officer | 2 | $105.0K | $0 | 2017-08-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Azoy Alexander | Chief Financial Officer | F Tax w/h | 2019-10-02 | 2019-10-04 | 2,396 | $0.23 | $551 | 103,552 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-08-06 | 2019-08-08 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-08-06 | 2019-08-08 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Beddingfield III Frederick | President & CEO | D To issuer deriv | 2019-08-06 | 2019-08-08 | 190,910 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | D To issuer deriv | 2019-08-06 | 2019-08-08 | 42,590 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | D To issuer deriv | 2019-08-06 | 2019-08-08 | 40,968 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | D To issuer deriv | 2019-08-06 | 2019-08-08 | 93,750 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | D To issuer deriv | 2019-08-06 | 2019-08-08 | 93,750 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-08-06 | 2019-08-08 | 42,590 | — | $0 | 42,590 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-08-06 | 2019-08-08 | 190,910 | — | $0 | 190,910 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-08-06 | 2019-08-08 | 40,968 | — | $0 | 40,968 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 0 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 14,904 | — | $0 | 14,904 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 48,720 | — | $0 | 48,720 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 11,926 | — | $0 | 11,926 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 0 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 14,904 | — | $0 | 0 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 11,926 | — | $0 | 0 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 48,720 | — | $0 | 0 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 8,750 | — | $0 | 0 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 8,750 | — | $0 | 0 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 5,600 | — | $0 | 0 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | D To issuer deriv | 2019-08-06 | 2019-08-08 | 25,000 | — | $0 | 0 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award deriv | 2019-08-06 | 2019-08-08 | 5,600 | — | $0 | 5,600 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | D To issuer deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 0 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-08-06 | 2019-08-08 | 18,290 | — | $0 | 18,290 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-08-06 | 2019-08-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-08-06 | 2019-08-08 | 8,518 | — | $0 | 8,518 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | D To issuer deriv | 2019-08-06 | 2019-08-08 | 60,000 | — | $0 | 0 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | D To issuer deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 0 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-08-06 | 2019-08-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | D To issuer deriv | 2019-08-06 | 2019-08-08 | 18,290 | — | $0 | 0 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | D To issuer deriv | 2019-08-06 | 2019-08-08 | 8,518 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award | 2019-08-06 | 2019-08-08 | 150,000 | — | $0 | 967,599 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award | 2019-08-06 | 2019-08-08 | 55,000 | — | $0 | 196,488 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award | 2019-08-06 | 2019-08-08 | 70,000 | — | $0 | 105,948 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award | 2019-08-06 | 2019-08-08 | 50,000 | — | $0 | 145,558 | SEC↗ |
| Beddingfield III Frederick | President & CEO | F Tax w/h | 2019-07-02 | 2019-07-03 | 17,063 | $0.76 | $13.0K | 817,599 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | F Tax w/h | 2019-07-02 | 2019-07-03 | 1,552 | $0.76 | $1.2K | 35,948 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | F Tax w/h | 2019-07-02 | 2019-07-03 | 4,095 | $0.76 | $3.1K | 141,488 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | F Tax w/h | 2019-07-02 | 2019-07-03 | 4,095 | $0.76 | $3.1K | 95,558 | SEC↗ |
| Stroehmann Diane | See Remarks | F Tax w/h | 2019-07-02 | 2019-07-03 | 4,095 | $0.76 | $3.1K | 168,545 | SEC↗ |
| FENTON DENNIS M | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Harris Todd | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hindman James M. | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Leonard Keith R | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MORE ROBERT J | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Burow Kristina | Director, 10% Owner | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award deriv | 2019-04-01 | 2019-04-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Azoy Alexander | Chief Financial Officer | A Award | 2019-04-01 | 2019-04-03 | 20,000 | — | $0 | 37,500 | SEC↗ |
| Beddingfield III Frederick | President & CEO | P Buy | 2019-02-22 | 2019-02-26 | 40,000 | $2.50 | $100.0K | 831,662 | SEC↗ |
| Leonard Keith R | Director | P Buy | 2019-02-22 | 2019-02-26 | 100,000 | $2.50 | $250.0K | 100,000 | SEC↗ |
| MORE ROBERT J | Director | P Buy | 2019-02-22 | 2019-02-26 | 100,000 | $2.50 | $250.0K | 255,942 | SEC↗ |
| Burow Kristina | Director | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| Burow Kristina | Director | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| Burow Kristina | Director | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| ARCH Venture Partners VIII, L. | 10% Owner | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| ARCH Venture Partners VIII, L. | 10% Owner | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| ARCH Venture Partners VIII, L. | 10% Owner | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-01-01 | 2019-01-03 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-01-01 | 2019-01-03 | 93,750 | — | $0 | 187,500 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2019-01-01 | 2019-01-03 | 40,968 | — | $0 | 40,968 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-01-01 | 2019-01-03 | 18,290 | — | $0 | 18,290 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 45,000 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 45,000 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2019-01-01 | 2019-01-03 | 14,904 | — | $0 | 14,904 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2019-01-01 | 2019-01-03 | 14,422 | — | $0 | 14,422 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 45,000 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Stroehmann Diane | See Remarks | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Stroehmann Diane | See Remarks | A Award deriv | 2019-01-01 | 2019-01-03 | 14,632 | — | $0 | 14,632 | SEC↗ |
| Stroehmann Diane | See Remarks | A Award deriv | 2019-01-01 | 2019-01-03 | 22,500 | — | $0 | 45,000 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award | 2019-01-01 | 2019-01-03 | 187,500 | — | $0 | 791,662 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award | 2019-01-01 | 2019-01-03 | 45,000 | — | $0 | 99,653 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award | 2019-01-01 | 2019-01-03 | 45,000 | — | $0 | 142,583 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award | 2019-01-01 | 2019-01-03 | 45,000 | — | $0 | 46,657 | SEC↗ |
| Stroehmann Diane | See Remarks | A Award | 2019-01-01 | 2019-01-03 | 45,000 | — | $0 | 172,640 | SEC↗ |
| Hindman James M. | Director | A Award deriv | 2018-08-01 | 2018-08-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2018-07-15 | 2018-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2018-06-01 | 2018-06-04 | 190,910 | — | $0 | 190,910 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2018-06-01 | 2018-06-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2018-06-01 | 2018-06-04 | 48,720 | — | $0 | 48,720 | SEC↗ |
| Stroehmann Diane | See Remarks | A Award deriv | 2018-06-01 | 2018-06-04 | 48,720 | — | $0 | 48,720 | SEC↗ |
| Leonard Keith R | Director | A Award deriv | 2018-06-01 | 2018-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FENTON DENNIS M | Director | A Award deriv | 2018-06-01 | 2018-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MAST ERLE T | Director | A Award deriv | 2018-06-01 | 2018-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MORE ROBERT J | Director | A Award deriv | 2018-06-01 | 2018-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2018-06-01 | 2018-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | A Award deriv | 2018-06-01 | 2018-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Beddingfield III Frederick | President & CEO | J Other | 2018-05-17 | 2018-05-21 | 47,594 | — | $0 | 601,246 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-30 | 2018-05-02 | 100 | $20.00 | $2.0K | 570,991 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-25 | 2018-04-25 | 300 | $20.00 | $6.0K | 571,091 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-24 | 2018-04-25 | 150 | $20.00 | $3.0K | 571,391 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-23 | 2018-04-25 | 525 | $20.00 | $10.5K | 571,541 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-18 | 2018-04-19 | 15,810 | $20.09 | $317.6K | 572,066 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-17 | 2018-04-19 | 2,201 | $20.00 | $44.0K | 587,876 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2018-04-16 | 2018-04-18 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-10 | 2018-04-12 | 3,779 | $20.02 | $75.7K | 590,077 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-09 | 2018-04-09 | 2,824 | $20.00 | $56.5K | 593,856 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-04-05 | 2018-04-09 | 5,386 | $20.00 | $107.7K | 596,680 | SEC↗ |
| MORE ROBERT J | Director | S Sale | 2018-03-29 | 2018-03-29 | 14,429 | $18.78 | $271.0K | 178,820 | SEC↗ |
| MORE ROBERT J | Director | S Sale | 2018-03-28 | 2018-03-29 | 10,000 | $18.84 | $188.4K | 193,249 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-03-19 | 2018-03-20 | 5,876 | $20.00 | $117.5K | 602,066 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-03-12 | 2018-03-14 | 3,452 | $20.11 | $69.4K | 607,942 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-03-09 | 2018-03-09 | 2,438 | $20.01 | $48.8K | 611,394 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-03-08 | 2018-03-09 | 14,530 | $20.03 | $291.0K | 613,832 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | S Sale | 2018-03-07 | 2018-03-09 | 3,704 | $20.00 | $74.1K | 628,362 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2017-11-01 | 2017-11-02 | 5,315 | — | $0 | 5,315 | SEC↗ |
| Leonard Keith R | Director | A Award deriv | 2017-11-01 | 2017-11-02 | 5,315 | — | $0 | 5,315 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | A Award deriv | 2017-11-01 | 2017-11-02 | 5,315 | — | $0 | 5,315 | SEC↗ |
| FENTON DENNIS M | Director | P Buy | 2017-09-18 | 2017-09-19 | 1,250 | $22.96 | $28.7K | 1,250 | SEC↗ |
| Beddingfield III Frederick | President & CEO | C Conversion deriv | 2017-08-01 | 2017-08-01 | 14,076 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | C Conversion deriv | 2017-08-01 | 2017-08-01 | 14,076 | — | $0 | 0 | SEC↗ |
| Beddingfield III Frederick | President & CEO | C Conversion deriv | 2017-08-01 | 2017-08-01 | 112,614 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 0 | SEC↗ |
| Leonard Keith R | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 31,784 | — | $0 | 0 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | C Conversion deriv | 2017-08-01 | 2017-08-01 | 10,557 | — | $0 | 0 | SEC↗ |
| MORE ROBERT J | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 32,892 | — | $0 | 0 | SEC↗ |
| MORE ROBERT J | Director | C Conversion deriv | 2017-08-01 | 2017-08-01 | 136,286 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 0 | SEC↗ |
| Stroehmann Diane | See Remarks | C Conversion deriv | 2017-08-01 | 2017-08-01 | 28,153 | — | $0 | 0 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 0 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 0 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 0 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion deriv | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 0 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | P Buy | 2017-08-01 | 2017-08-01 | 15,000 | $15.00 | $225.0K | 15,000 | SEC↗ |
| Beddingfield III Frederick | President & CEO | C Conversion | 2017-08-01 | 2017-08-01 | 112,614 | — | $0 | 112,614 | SEC↗ |
| Beddingfield III Frederick | President & CEO | C Conversion | 2017-08-01 | 2017-08-01 | 14,076 | — | $0 | 14,076 | SEC↗ |
| Beddingfield III Frederick | President & CEO | C Conversion | 2017-08-01 | 2017-08-01 | 14,076 | — | $0 | 14,076 | SEC↗ |
| Burow Kristina | Director | C Conversion | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 2,750,575 | SEC↗ |
| Burow Kristina | Director | C Conversion | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 2,538,641 | SEC↗ |
| Burow Kristina | Director | C Conversion | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 882,493 | SEC↗ |
| Burow Kristina | Director | C Conversion | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 563,072 | SEC↗ |
| Leonard Keith R | Director | P Buy | 2017-08-01 | 2017-08-01 | 16,700 | $15.00 | $250.5K | 16,700 | SEC↗ |
| Leonard Keith R | Director | C Conversion | 2017-08-01 | 2017-08-01 | 31,784 | — | $0 | 31,784 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | P Buy | 2017-08-01 | 2017-08-01 | 10,000 | $15.00 | $150.0K | 94,634 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | C Conversion | 2017-08-01 | 2017-08-01 | 10,557 | — | $0 | 10,557 | SEC↗ |
| MAST ERLE T | Director | P Buy | 2017-08-01 | 2017-08-01 | 6,700 | $15.00 | $100.5K | 6,700 | SEC↗ |
| MORE ROBERT J | Director | C Conversion | 2017-08-01 | 2017-08-01 | 136,286 | — | $0 | 170,357 | SEC↗ |
| MORE ROBERT J | Director | C Conversion | 2017-08-01 | 2017-08-01 | 32,892 | — | $0 | 203,249 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 2,538,641 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 2,750,575 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 563,072 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 882,493 | SEC↗ |
| PETERSON RICHARD D | Chief Financial Officer | P Buy | 2017-08-01 | 2017-08-01 | 7,000 | $15.00 | $105.0K | 7,000 | SEC↗ |
| Stroehmann Diane | See Remarks | P Buy | 2017-08-01 | 2017-08-01 | 7,000 | $15.00 | $105.0K | 124,724 | SEC↗ |
| Stroehmann Diane | See Remarks | C Conversion | 2017-08-01 | 2017-08-01 | 28,153 | — | $0 | 117,724 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 882,493 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 563,072 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 2,750,575 | SEC↗ |
| ARCH Venture Fund VIII, L.P. | 10% Owner | C Conversion | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 2,538,641 | SEC↗ |
| Andrews Timothy K. | General Counsel & Secretary | A Award deriv | 2017-07-26 | 2017-07-27 | 8,518 | — | $0 | 8,518 | SEC↗ |
| Beddingfield III Frederick | President & CEO | A Award deriv | 2017-07-26 | 2017-07-27 | 42,590 | — | $0 | 42,590 | SEC↗ |
| Harris Todd | Head of Corporate Developmen | A Award deriv | 2017-07-26 | 2017-07-27 | 11,926 | — | $0 | 11,926 | SEC↗ |
| Lizzul Paul F. | Chief Medical Officer | A Award deriv | 2017-07-26 | 2017-07-27 | 11,926 | — | $0 | 11,926 | SEC↗ |
| PETERSON RICHARD D | Chief Financial Officer | A Award deriv | 2017-07-26 | 2017-07-27 | 8,518 | — | $0 | 8,518 | SEC↗ |
| Stroehmann Diane | See Remarks | A Award deriv | 2017-07-26 | 2017-07-27 | 11,926 | — | $0 | 11,926 | SEC↗ |